Last $21.98 USD
Change Today +0.25 / 1.15%
Volume 97.9K
CBM On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 12:43 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

cambrex corp (CBM) Snapshot

Open
$21.50
Previous Close
$21.73
Day High
$22.07
Day Low
$21.38
52 Week High
07/14/14 - $22.55
52 Week Low
09/6/13 - $12.56
Market Cap
671.2M
Average Volume 10 Days
174.7K
EPS TTM
$0.64
Shares Outstanding
30.6M
EX-Date
05/4/07
P/E TM
34.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for CAMBREX CORP (CBM)

cambrex corp (CBM) Related Bloomberg News

View More Bloomberg News

cambrex corp (CBM) Related Businessweek News

No Related Businessweek News Found

cambrex corp (CBM) Details

Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. Its products consist of active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products. The company serves generic drug companies, and companies that discover and commercialize new small molecule human therapeutics. The company sells its products directly, as well as through independent agents. Cambrex Corporation was founded in 1981 and is headquartered in East Rutherford, New Jersey.

936 Employees
Last Reported Date: 02/11/14
Founded in 1981

cambrex corp (CBM) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $533.3K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $400.0K
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $412.5K
Managing Director of Cambrex Profarmaco Milan...
Total Annual Compensation: $338.7K
Compensation as of Fiscal Year 2013.

cambrex corp (CBM) Key Developments

Cambrex Names James Winschel to Board of Directors

Cambrex Corp. reported that James Winschel was appointed to the company's Board of Directors for a term expiring on the date of its 2015 annual meeting and will serve on the Board's Audit Committee and Regulatory Affairs Committee. The company noted that Winschel's appointment maintains the size of the Board at nine members following John Miller's retirement in April. Following 13 years as Senior Vice President and Chief Financial Officer of Parexel International Corp., Winschel was named Executive Vice President of Parexel in September 2013.

Cambrex Corporation Appoints James F. Winschel, Jr. to Board of Directors

Cambrex Corporation announced that James F. Winschel, Jr. was appointed to the company's board of directors for a term expiring on the date of its 2015 annual meeting and will serve on the board's Audit Committee and Regulatory Affairs Committee. Mr. Winschel's appointment maintains the size of the board at nine members following John Miller's retirement in April. Prior to joining PAREXEL, Mr. Winschel served as President of U.B. Vehicle Leasing Inc.

Cambrex Corporation. Presents at Jefferies 2014 Global Healthcare Conference, Jun-02-2014 09:30 AM

Cambrex Corporation. Presents at Jefferies 2014 Global Healthcare Conference, Jun-02-2014 09:30 AM. Venue: Grand Hyatt, New York, New York, United States. Speakers: Steven M. Klosk, Chief Executive Officer, President and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CBM:US $21.98 USD +0.25

CBM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aceto Corp $17.63 USD -0.27
Biocon Ltd 479.90 INR -38.00
Codexis Inc $1.96 USD +0.02
Piramal Enterprises Ltd 623.35 INR -14.85
Produits Chimiques Auxiliaires et de Synthese €4.15 EUR 0.00
View Industry Companies
 

Industry Analysis

CBM

Industry Average

Valuation CBM Industry Range
Price/Earnings 33.9x
Price/Sales 2.2x
Price/Book 3.1x
Price/Cash Flow 42.6x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CAMBREX CORP, please visit www.cambrex.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.